PharmaCyte Biotech, Inc. (NASDAQ: PMCB) today announced that its Board of Directors (Board) has authorized a share repurchase program to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE